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Microsclerodermins A and B. Antifungal Cyclic Peptides from 
the Lithistid Sponge Microscleroderma sp. 
Carole A. Bewley? Cécile Debitus,$ and D. John Faulkner'J 
Sponges of the order Lithistida produce some of the most 
bioactive and complex marine natural products, among which 
are the cyclotheonamides,' the calyculins,2 discodermolide,3 the 
onnamides? theonellamide F,S and swinholide.6 We became 
interested in lithistidsponges because they often contain symbiotic 
filamentous bacteria in the interior of the sponge. Our aim is to 
investigate the roleof symbionts, suchas the filamentous bacteria, 
in the production of sponge metabolites by determining thecellular 
location of the metabolites. At the same time we recognized that 
the structural elucidation of the antifungal cyclic peptides from 
lithistid sponges would present an interesting challenge. In this 
paper we report the structural elucidation of two new cyclic 
peptides microsclerodermins A (1) and B (2) from a deep-water 
sponge and comment on the nature of the symbiotic filamentous 
bacterium associated with the sponge. 
A specimen of the lithistid sponge Microscleroderma sp. was 
collected by dredging at a depth of 1000 ft off the Norfolk Rise 
near New Caledonia. The sponge was freezedried and then 
extracted sequentially with hexanes, ethyl acetate, and 50% 
aqueous acetonitrile. The crude aqueous extract showed anti- 
fungal activity against Botrytis cinerea, Candida albicans, 
Fusarium oxysporum, Helminthosporium sativum, and Py- 
ricularia oryzae. Bioassay-guided fractionation of the aqueous 
extract using C. albicans as the test organism7 resulted in the 
isolation of two polar antifungal metabolites, microsclerodermins 
A (1, 0.005% dry wt) and B (2,0.001% dry wt). 
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1 R = O H  
2 R = H  
Microsclerodermin A (1) has the molecular formula C47H62- 
N*O16, as determined by HRMS [ m / z  = 995.4395 (M + H)+], 
but readily loses one molecule of water on treatment with mild 
acid or dehydrating agents to obtain dehydromicrosclerodermin 
A [3,m/z= 977 (M+H)+]. Thepeptidalnatureofthecompound 
H 
1 was indicated by the FTIR and NhhR spectra. Methylation of 
1 with diazomethane in ethanol produced a monomethyl ester 
(myz = 1008) while acetylation of either 1 or 3 with acetic 
anhydride in pyridine containing DMAP gave the same pen- 
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taacetate [m/z = 1187 (M + H)+], indicating the presence of 
one carboxylic acid and six hydroxyl groups in 1. The 1H NMR 
spectrum in DMSO-& contained six amide NH signals between 
6 7.15 and 8.05, an N-methyl signal at 2.85, and an indole NH 
signal at 10.5, accounting for all eight of the nitrogen atoms. The 
13C NMR spectrum revealed eight carbonyls, seven involved in 
amide linkages and one carboxylic acid, that together with an 
O-methyl group and the six hydroxyl groups account for all of 
the oxygen atoms. 
Standard amino acid analysis revealed that glycine was the 
only common amino acid in 1. N-Methylglycine and 4-amino- 
3-hydroxybutyric acid were easily identified by interpretation of 
the NMR data (see Table 1). Analysis of the aromatic region 
of the lH and 13C NMR spectra provided evidence for an indole 
ring system that was substituted at both the 2- and 3-positions, 
(2-31 and C-32, respectively. The HMBC8 spectrum showed 
corrdations between both H-29 signals and C-27, C-28, C-31, 
C-32, and C-33,which indicated alkyl substitution at the 3-position 
(C-32). The assignment of a carboxylic acid residue at the 
2-position (C-32) was based on comparison of the 13C chemical 
shift of 61-31 at 6 117.5 with those of model compounds, such as 
3,5-dimethylpyrrole-2-carboxylic acid ('2-26 1 lT.4)gaand 3-meth- 
ylindole-2-carboxylic acid (C-2:6 117.8).9b These data fully 
support the presence of a tryptophan-2-carboxylic acid residue, 
which appears to be undescribed. The identity of the pyrrolidone 
ring system within the C-42 to C-47 portion of 1 was elucidated 
by analysis of the NMR spectra, particularly the HMBC data, 
and by comparing the NMR data of 1 with those of 3. The 
isolated methylene group appeared in the lH NMR spectrum as 
two doublets at 6 2.52 and 2.78 which, in the HMBC spectrum, 
are correlated with C-42, C-44, and C-45. The chemical shift 
of C-44 at 6 82.0 (s) is appropriate for a carbon bearing both a 
hydroxyl and an N-acyl group. The HMBC correlations from 
H-45 to all of the ring carbons and the correlations between 
NB-44 and the ring carbons defined the pyrrolidone ring system. 
On dehydration, a new double bond is formed from (2-43 (6 88.8) 
to C-44 (6 152.8); the NMR data of 3 (see Table 2) are consistent 
with the formation of a 3-hydaoxy-4-amido-5-vinylpyrrolidone 
ring system.10 
The aromatic region of the lH NMR spectrum contained signals 
for a p-substituted benzene ring at 6 6.84 (d, 2 H, J = 8.5 Hz) 
and 7.28 (d, 2 H, J = 8.5 Hz) and a disubstituted olefin at 6 6.28 
(d, 1 H, J = 15.5 Hz) and 6.10 (dt, 1 H, J = 15.5, 7 Hz) that, 
on analysis of the 13C NMR and HMBC data, were shown to 
constitute a p-methoxy-tram-styrene moiety. The C- 1 to C-6 
portion of the molecule was difficult to establish by NMR 
spectroscopy because the signals at 6 4.42 (br s, 1 H) and 4.15 
(dd, 1 H, J =  10,9 Hz) are not coupled, implying that thedihedral 
angle betweens-2 and H-3 is about 90". However, theROESY" 
spectrum clearly indicated the proximity of these hydrogens. The 
placement of an amide functionality at C-3 and hydroxyls at (2-2, 
(2-4, and C-5 was based on the lH and 13C NMR chemical shifts. 
The isolation of the intact C-1 to C-4 unit as 0-hydroxyaspartic 
acid (see below) confirmed the C-1 to C-5 assignments. A methyl 
group was positioned at C-6 on the basis of HMBC data. This 
left only four methylene signals in the 13C spectrum unassigned, 
and the COSY, TOCSY, and HMBC data were used to place 
Bewley et al. 
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them as a methylene chain from C-7 to C-10. At this stage we 
have identified six amino acid residues and, by analysis of the 
unsaturation equivalents, determined that 1 was a cyclic peptide. 
Linkages between the amino acid residues were established by 
interpretation of the HMBC and ROESY data to obtain the 
planar structure for microsclerodermin A (1). 
The stereochemistry of 1 was determined by a series of 
degradation experiments coupled with analysis of NOE data. In 
each of the sub-milligram-scale degradation reactions, the amino , 
acids were analyzed as their pentafluoropropionamide N-isopropyl 
ester derivatives by GC-MS using a chiral capillary column. 
Hydrolysis of 1 using 6 N hydrochloric acid at 100 OC in a sealed 
tube gave racemic 3-hydroxy-4aminobutyric acid,l2 but treatment 
of 1 with neat methanesulphonic acid at 110 OC in a sealed tube 
gave (3R)-3-hydroxy-4-aminobutyric acid. The (R)-stereo- 
chemistry at the a-carbon in the tryptophan-2-carboxylic acid 
residuewasestablished byozonolysisof 1,followed by anoxidative 
workup and hydrolysis of the product with 6 N hydrochloric acid 
to obtain (R)-aspartic acid. Ozonolysis of 3 followed by hydrolysis 
of the reaction product with 6 N hydrochloric acid gave (2S,3R)- 
3-hydroxyaspartic acid, indicating that the stereochemistry in 
the pyrrolidone ring must be (45S,46R)l. The (44S)-stereo- 
chemistry was determined by the observation of WOESY 
correlations between H-43, H-45; and H-46. Cleavage of the 
(2-4, C-5 diol withsodium periodate, followed by oxidativeworkup 
and hydrolysis with 6 N hydrochloric acid, gave (2sY3S)-3- 
hydroxyasparticacid, which requires the (2s,3R)-stereochemistry 
in 1. Thestereochemistry about the C-4, C-5 diol was established 
by treating 3 with dimethoxypropane in DMF to obtain the 
a~etonide4.l~ TheROESY experiment on theacetonideindicated 
a threo relationship between the hydroxyl groups at C-4 and C-5. 
Furthermore, examination of molecular models showed that the 
observed NOE correlations were consistent with the (2S,3R,- 
4S,SS)-stereochemistry but not the (2SY3R,4R,5R)-stereochem- 
istry (see Figure 1). The (6S)-stermchemistry was also assigned 
from the ROESY data. Examination of the molecular model 
showed that the correlations between H-6 and both €3-4 and H-5 
and beiween the methyl group at C-6 and H-5 were only possible 
for the (6S)-stereochemistry (see Figure 1). 
(a) @) 
Figure 1. Nuclear Overhauser enhancements used to establish (a) the 
2&3R,4S,SS stereochemistjand (b) the6Sstereochemistry. Alternative 
stereochemical arrangements cannot account for all of the observed NOE 
correlations. 
Microsclerodermin B (2) has the molecular formula C47H62- 
NsOls, as revealed by the low-resolution mass spectrum (m/z = 
978.4) and thehigh-resolutionmass spectmof thecorresponding 
dehydro derivative [m/z = 961.4256 (M + H)+]. Analysis of 
theNMR data revealed that the only change was thereplacement 
of the hydroxyl group at C-46 by hydrogen. The key differences 
in the NMR data are that the signals at 60: 70.9 and 8~ 4.12 (br 
d, 1 H, J = 7.5 Hz) in 11 are replaced by signals at 6~ 32.6 ,and 
6~ 2.43 (dd, 1 H, J =  17,5.5 Hz) and 2.75 (dd, 1 H, J = 17, 10 
Hz) in 2. Otherwise, the similarity between the spectral data of 
1 and 2 strongly suggests that the stereochemistry of microscle- 
rodermin B (2) is the same as that of microsclercdermin A (1). 
(12) Rossiter, B. E.; Sharpless, K. B. J.  Org. Chem. 1984,49, 3707. 
113) Alternative acetonides were ruled out by analysis of the 'H NMR - .  
spectrúm. 
Microsclerodermins A and B 
Table 1. Correlated 13C and 1H NMR Spectral Data and Proton-Proton NOE Data for Microsclerodermin A (1) 
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amino 6” 
acid assignment *3C (mult)b ‘H (mult, J (Hz))e HMBCe NOEcd 
AMMTDC 
GABOW 
GlY 
Trp-2COOH 
NMeGly 
pyrrolidone 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
NH3 
OH2 
OH4 
OH5 
21 
22 
23 
24 
NH24 
OH23 
25 
26 
NH26 
27 
2s 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
NH28 
indoleNH 
COOH30 
39 
40 
41 
42 
43 
44 
45 
46 
47 
NH44 
OH44 
NH45 
OH46 
173.5 (s) 
69.3 (d) 
53.5 (d) 
68.4 (d) 
72.9 (d) 
34.6 (d) 
32.7 (t) 
26.0 t 
29.6 (t) 
32.5 (t) 
128.4 (d) 
128.9 (d) 
130.3 (s) 
126.9 (d) 
113.9 (d) 
158.0 (s) 
114.0 (d) 
126.9 (d) 
15.5 (9) 
55.1 (9) 
172.5 (s) 
40.9 (t) 
66.9 (d) 
45.2 (t) 
169.0 (s) 
42.8 (t) 
171.7 (s) 
56.0 (d) 
25.4 (t) 
163.5 (s) 
117.5 (s) 
125.2 (s) 
127.9 (s) 
120.2 (d) 
119.44d) 
124.3 (d) 
112.3 (d) 
135.9 (s) 
170.6 (s) 
49.3 (t) 
36.2 (9) 
39.5 (t) 
170.7 (s) 
82.0 (s) 
59.2 (d) 
70.9 (d) 
173.5 (s) 
4.42 (brs) 
4.15 (dd, 10.0,g.O) 
3.42 (brd, 9.0) 
3.05 (m) 
1.56 (m) 
1.00 (m) 
1.70(m) . 
1.19 (m) 
1.37 (m) 
1.38 (m) 
2.12 (m) 
6.10 (ddd, 15.5,7.0,7.0) 
6.28 (d, 15.5) 
7.28 (d, 8.5) 
6.84 (d, 8.5) 
6.84 (d, 8.5) 
7.28 (d, 8.5) 
0.75 (d, 6.0) 
3.72 (s) 
7.25 (d, 10.0) 
6.28 
4.28 
4.08 
2.11 (dd, 10.5,14.0) 
2.39 (dd, 2.5,14.0) 
3.72 (m) 
2.60 (m) 
3.36 (m) 
7.40 (dd, 5.5,5.5) 
4.80 
3.13 (dd, 17.5,5.5) 
3.55 (dd, 17.5,5.5) 
8.30 (dd, 5.5,5.5) 
4.09 (ddd, 5.0,5.5,5.5) 
3.38 (dd, 13.0,5.5) 
3.46 (dd, 13.0,5.5) 
7.52 (d, 8.0) 
7.05 (dd, 8.0,S.O) 
7.21 (dd, 8.0,S.O) 
7.38 (d, 8.0) 
8.72 (d, 5.0) 
11.50 (s) 
13.00 (br s) 
3.53 (d, 16.0) 
4.42 (d, 16.0) 
2.89 (s) 
2.52 (d) 
2.78 (d) 
4.22 (dd, 8.0,7.5) 
4.12 (brd, 7.5) 
8.05 (s) 
h 
7.45 (d, 8.0) 
5.56 
c 1  
C4,21 
c 3  
C5,8  
C8 
C8 
c 7  
C8,lO 
C8,9,  11 
C13 
C13,14,18 
C12,15,16, 18 
C13,16,17 
C13,15,16 
C12, 14, 16, 17 
C5,6 ,7  
C16 
c 2  1 
C:21,23 
C21,23 
C22,23 
C22,23 
C25,27 
C25,27 
C26,27 
C27,29 
C27,28,31,32,33 
C27,28,31,32,33 
C36,38 
C33,37 
C34,38 
c.33,35 
c39 
C31,32,33,38 
C39,41,42 
C39,41,42 
C40,42 
C42,44,45 
C42,44,45 
C43,44,46,47 
C45,47 
C44,45,46 
C l ,  45,46 
c45  
3,4,NH3,NH45,OH2 
2,NH3,gOH4 
2,5,19,NH3, OH2,OH4, OH5 
4,6,g7’,g 19,NH3,gOH5 
4,5+’19,OH4,OH59 
5,g 6,g 7’, 8‘ 
5,7’,OH5g 
6,7‘, 9, 10 
6,7‘, 9, 10 
10 , l l  
5,9,11, 12 
9,lO 
10 
20 
20 
4,5,6 
22‘,NH3,9NH24,OH5 
4,22,239 
2,4,NH3,NH24 
2,35 6 
3,5,6,8 7‘8 
22’, 23 
22,23,24,41,gNH3, NH24 
22’,NH3,gNH24,OH23 
24’,NH24 
24, NH24 
22’, 23,24,24’, 26‘,KOH23 
22,23, NH3, NH24.. 
26: NH26 
26, NH24, NH269 
26,28 
29,29’, 34 
28,29’, 34 
29,34 
28,29,29’, 40’ 
28,40‘ 
37 
40’, 41, NH24 
40 
40,43 
41,43‘, 45,46, NH44 
41,43 
43, NH44,g NH45,0H46 
43,45, NH44,g NH45,0H46 
43,455 469 
2,45,g46$0H2 
45,46 
“Referenced to residual solvent DMSO-ds. fi I3C spectra recorded on a Bruker WP2OOSY at 50 MHz. ‘H spectra recorded on a Varian Unity 500 
at 500 MHz. Spin lock used. AMMTD = (2S,3R,4S,5S,6S,11E)-3-amino-6-methy1-12-(p-methoxyphenyl)-2,4,5-ttihydroxydode-1l-enoic acid. 
/GABOB = (3R)-4-amino-3-hydroxybutyric acid. g Weak NOE. Not observed. 
Both microsclerodermins A (1) and B (2) inhibit the growth 
of C. albicans at a loading of 2.5 figfdisk in the standard disk 
assay? We have examined a number of lithistid sponges from 
both shallow-water and deep-water environments and found that 
1634 J. Am. Chem. Soc., Vol. 116, No. 17, P994 
Table 2. Correlated I3C and 'H NMR Spectra Data and Proton-Proton NOE data for Dehydromicroscberodermin A (3) 
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P amino 
acid assignment 13C (multY lH (mult, J (HZ))~ HMBQ NOECJ 
AMMTDe 
GABOU 
GlY 
Trp-2COOH 
NMeGly 
pyrrolidinone 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
NH3 
OH2 
OH4 
OH5 
21 
22 
23 
24 
NH24 
OH23 
25 
26 
NH26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
"28 
indoleNH 
COOH30 
39 
40 
41 
42 
43 
44 
45 
46 
47 
NH44 
OH45 
NH45 
OH46 
174.5 (s) 
69.5 (d) 
54.0 (d) 
68.7 (d) 
73.0 (d) 
34.1 (d) 
32.8 (t) 
26.3 (t) 
29.7 (t) 
32.6 (t) 
128.5 (d) 
129.0 (d) 
130.3 (s) 
127.2 (d) 
114.0 (d) 
158.0 (s) 
114.0 (d) 
127.2 (d) 
15.5 (9) 
55.3 (9) 
170.3 (s) 
41.0 (t) 
67.1 (d) 
45.8 (t) 
169.3 (s) 
43.0 (t) 
171.3 (s) 
56.0 (d) 
25.1 (t) 
163.5 (s) 
117.5 (s) 
125.2 (s) 
127.9 (s) 
120.2 (d) 
119.4 (d) 
124.3 (d) 
112.3 (d) 
135.9 (s) 
170.6 (s) 
49.5 (t) 
36.5 (9) 
168.0 (s) 
88.8 (d) 
152.8 (s) 
55.1 (d) 
71.6 (d) 
174.5 (s) 
4.45 (brs) 
4.08 (dd, 10.0,g.O) 
3.41 (brd, 9.0) 
3.05 (m) 
1.56 (m) 
1.00 (m) 
1.70 (m) 
1.18 (m) 
1.38 (m) 
1.38 (m) 
2.114 (m) 
6.30 (d, 15.5) 
7.28 (d, 8.5) 
6.84 (d, 8.5) 
6.84 (d, 8.5) 
7.28 (d, 8.5) 
0.75 (d, 6.0) 
3.70 (s) 
7.15 (d, 10.0) i 
6.25 
4.30 
4.10 
2.08 (dd, 10.5,14.0) 
2.30 (dd, 2.5, 14.0) 
3.65 (m) 
2.60 (m) 
3.40 (m) 
7.44 (dd, 5.5,5.5) 
5.05 
3.28 (dd, 17.5,5.5) 
3.60 (dd, 17.5,5.5) 
8.28 (dd, 5.5, 5.5) 
4.100 (ddd, 5.0,5.5,5.5) 
3.37 (dd, 13.0,5.5) 
3.53 (dd, 13.0,5.5) 
6.110 (d'ad, 15.5,7.0,7.0) 
7.52 (d, 8.0) 
7.05 (dd, 8.0.8.0) 
7.21 (dd, 8.0, 8.0) 
7.38 (d, 8.0) 
8.72 (d, 5.0) ' 
11.50 (s) 
13.00 (br s) 
3.36 (d, 16.0) 
4.48 (d, 16.0) 
2.85 (s) 
5.10 (d, 1.5) 
4.82 (ddd, $.O, 7.5, 1.5) 
4.40 (brd, 7.5) 
10.50 ~(s) 
h 
8.37 (d, 8.0) 
6.05 
C:l, 3 
c 4 , 2 1  
C6 
C8,lO 
C:8,9 
C:9,10,13 
C:10,13, 14,18 
C12,15, 16,18 
C13,16,17 
C13,15, 16 
C12,14, 16,17 
C5,6  
C16 
c21 
C l ,  2,3 
C21,23 
C21,23 
C25 
C25,27 
C.25,27 
C26,27 
C.27,28,31,33 
C27,28,31,33 
C35,36,38 
c:33,37 L 
C34,38 
c 3 3  
c39 
C31,32,33,38 
C39,41,42 
C39,41,42 
C40,42 
C42,45 
C44,46 
c45,47 
C44,45,46,4;7 
C l ,  45 
3, NH45,0H2 
2, 5,NH3 
5,6,NH3,OH2,4 
4,6,7,NH3,OH5 
5,8,7, 19 
5-8 
538 
6,7,9 
6,7,9 
10,11 
9,11 
9, 10 
9, 10 
11,12, 15 
14,20 
18,20 
11,12, 17 
4 .5-67  
15,17 
4,5,22,22', NH45,OH2,0H5 
4,5,6,7 
394 
22', 24,438 NH3 
22,23,41,K43,gNH24 
22',43$NH24, 
24', NH24 
24,43, NH24 
22', 23,24,2#, NH459 
23,24' 
26',NH26 
26, NH26 
26,26', 28, NH216 
29, NH26,28 
28,29', 34, NH26 
28,29 
28,29,40' 
40' 
NH28 
40,43,22' 
22,s 24,841, NH45 
43, NH44,g NH45,0H46 
45, NH44k NH45,0H46 
45p 468 
2,43,45,46,NH3,OH2 
45,46 
Referenced to residual solvent DMSO-&. I3C spectra recorded on a Bruker WP2OOSY at 50 MHz. IH spectra recorded on a Varian Unity 500 
at 500 MHz. Spin lock used. e AMMTD = (2S,3R,4S,5S,BS,I lE)-3-amino-6-methyl-l2-(p-meth~xyphenyl)-2,4,5-~hydroxyd~~-ll-enoic acid.
fGABOB = (3R)-4-amino-3-hydroxybutyric acid. K Weak NOE. Not observed. 
not all lithistid sponges contain symbiotic filamentous microor- 
ganisms. However, it may be significant that, in the relatively 
small sample of lithistid sponges that we have examined (17 in 
total), there is a correlation between antifungal activity, which 
is attributed to the cyclic peptides possessing the o-phenyl-p- 
amino acids of various chain lengths, and the presence of the 
Microsclerodermins A and 3 
filamentous symbionts. Because of the similarities between 
compounds reported from lithistid sponges and those found in 
certain cyanobacteria, it  had been presumed that the symbionts 
were filamentous cyanobacteria. We became suspicious of this 
assignment because the filaments in the specimens we have studied 
do not autofluoresce and are found only in the interior of the 
sponge. In addition, lithistid sponges are often found in 
environments where there is little light and their crude extracts 
do not appear to contain chlorophyll. Examination of the filaments 
by transmission electron microscopy clearly reveals that,they are 
not cyanobacteria because they lack the characteristic thylakoid 
structures. Analysis of the TEM pictures suggests that the 
filamentous bacteria may be most closely related to those belonging 
to the family Beggiatoaceae,14 such as Beggiatoa sp., a filamentous 
bacterium that occurs as mats in deep-water environments such 
as the deep-sea vents. 
Experimental Section 
Instrumentation. UV and IR spectra were recorded on Perkin-Elmer 
Lambda 3B and 1600 series spectrometers, respectively. Optical rotations 
were measured on a Rudolph Autopol III polarimeter (c g/100 mL) at 
589 nm. NMR spectra were recorded on Varian Unity 500 and Bruker 
WP2OOSY spectrometers. Effective field strengths and mixing times 
used in the TOCSY'Sand ROESY*l experiments were 70 ms at 8.5 kHz 
and 100 ms at 2.0 kHz (Kessler spinlock used, 6 = 30°), respectively. 
Chiral GC-MS experiments were performed on a Hewlett Packard 5890A 
gas chromatogram fitted with an Alltech Chirasil-Val capillary column 
(0.32 mm X 25 m) and interfaced to a Hewlett Packard 5988A mass 
spectrometer. The oven temperature was ramped from 50 to 210 OC at 
4 OC/min and a mass range of 50-600 Da was recorded every 1.96 s. 
FAB mass spectra were measured on a VG ZAB mass spectrometer at 
the Regional Mass Spectrometry Facility, UC Riverside. 
Isolation The sponge Microsclerodermasp. (referencenumber R1466, 
ORSTOM Centre in Nouméa) was collected by dredging at ca. 1000 ft 
on the Norfolk Rise off the coast of New Caledonia. Following sorting, 
the sponge was immediately frozen and stored at -20 OC until being 
freeze-dried prior to extraction. The lyophilized sponge (600 g) was 
extracted with hexanes (2 X 800 mL to yield 600 mg of brown oil) and 
ethyl acetate (3 X 800 mL to yield 850 mg of amber oil), followed by 
exhaustive extraction with 50% aqueous CH3CN (until antifungal activity 
was no longer detected in the extract) to yield a salty powder (ca. 12 g). 
The aqueous extract was applied in 12 portions to (2-18 Sep-paks 
(Millipore-Waters, 10-g size) that were preconditioned by washing with 
75 mL of 80% and 40% aqueous CHaCN, followed by equilibration with 
150 mL of water. Following loading, the columns were washed with 
water (50 mL) and eluted sequentially with lo%, 20%, 30%, 50%, 60%, 
and 80% aqueous CH3CN (25 mL of each except for 50 mL of 50%). 
Fractionseluting with 50% aqueousCH3CNshowed reproducibleactivity 
against C. albicamand werecombined for further purificationon reversed- 
phase HPLC (YMC ODS-AM (300 mm X 10 mm); 40% CH3CN in 
0.05% TFA at 3.8 mL/min; UV detection, 215 nm) to obtain micro- 
sclerodermins A (1,27 mg, 0.005% dry wt) and B (2,6 mg, 0.001% dry 
wt). 
Microsclerodermin A (1): white powder; [ a ] ~  = -113O (c 0.53, 0.1 
M N W C O 3 ,  pH 7.O)J6UV (MeOH) (nm) 208 (e 7600), 260 (e2500), 
290 (e 1900); IR (KBr) 3310,3070,2930, 1660, 1540 cm-1; IH NMR 
(DMSO&) seeTable 1; 13C NMR(DMSO-&) seeTable 1; HRFABMS 
obsd m/z = 995.4395 (M +H)+, C47H63NsOl6requires m/z  = 995.4362. 
Microsclerodermin B (2): white powder; ["ID = -64' (c 0.23,O.l M 
NH4HCO3, pH 7.0); UV (MeOH) (nm) 204 (e 6100), 260 (e 2100), 290 
(E 1700);IR(KBr)3310,3070,2930,1660, 1540cm-';IHNMR(DMSO- 
d6) 8 0.75 (d, 3 H, J = 6 Hz, H-19), 1.00 (m, 1 H, H-7), 1.18 (m, 1 H, 
H-8), 1.37 (m, 1 H, H-8'),1.38 (m, 1 H, H-9), 1.56 (m, 1 H, H-6), 1.70, 
(m, 1 H, H-79, 2.03 (dd, 1 H, J = 14.5, 12 Hz, H-22), 2.14 (m, 1 H, 
Hz, H-46), 2.60 (m, 1 H, H-24), 2.75 (dd, 1 H, J = 17,lO Hz, H-46'), 
2.85 (s, 3 H, H-41), 3.05 (m. 1 H, H-5), 3.28 (dd, 1 H, J = 17.5, 5.5 
Hz, H-29), 3.39 (br d, 1 H, J = 13.5 Hz, H-4), 3.40 (m, 1 H, H-24'), 
H-lo), 2.32 (dd, 1 H , J =  12, 1.5 Hz, H-22'), 2.43 (dd, 1 H, J =  17,5.5 
Hz, H-26), 3.32 (d, 1 H, J = 16 Hz, H-40), 3.37 (dd, 1 H, J = 13,5.5 
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3.51 (dd, 1 H, J =  13.0,5.5 Hz, H-29'), 3.60 (dd, 1 H, J =  17.5,5.5 Hz, 
H-26'), 3.65 (m, 1 H, H-23), 3.70 (s, 1 H, H-20), 3.98 (ddd, 1 H, J = 
5.5, 5.5, 5 Hz, H-28), 4.08 (dd, 1 H, J = 13.5, 6 Hz, H-3), 4.10 (br s, 
1 H, OH-5), 4.30 (br s, 1 H, OH-4), 4.42 (br s, 1 H, H-2), 4.55 (d, 1 
(br s, 1 H, OH-23), 5.10 (s, 1 H, H-43), 6.10 (ddd, 1 H, J = 15.5, 7, 
7 Hz, H-11), 6.25 (br s, 1 H, OH-2), 6.30 (d, 1 H, J = 15.5 Hz, H-12), 
H, J = 16 Hz, H-40'), 4.82 (ddd, 1 H, J = 10, 9, 5.5 Hz, H-45), 5.05 
6.84 (d, 2 H, J = 8.5 Hz, H-15, -17), 7.05 (dd, 1 H, J = 8,8 HZ,.H-35), 
7.08 (d, 1 H, J = 6 Hz, NH-3), 7.22 (dd, 1 H, J = 8,8  Hz, H-36), 7.28 
(d, 2 H, J =  8.5 Hz, H-14, -18), 7.38 (d, 1 H, J = 8.0 Hz, H-37), 7.42 
(dd,lH,J=5.5,5.5Hz,NH-24),7.52(d,lH,J=8Hz,H-34),8.30 
(dd, 1 H, J = 5.5, 5.5 Hz, NH-26), 8.37 (d, 1 H, J = 9 Hz, NH-45), 
8.62 (d, 1 H, J = 5 Hz, NH-28), 10.5 (s, 1 H, NH-44); 13C NMR 
(DMSO-d6) 6 15.5 (q), 25.1 (t), 26.3 (t),29.7 (t), 32.6 (t), 32.8 (t), 34.1 
(d), 36.5 (q), 41.0 (t), 43.0 (t), 45.4 (t), 45.8 (t), 49.5 (t). 54.0 (d), 55.1 
(d), 55.3 (d), 56.0 (d), 67.1 (d), 68.7 (d), 69.5 (d), 74.2 (d), 87.6 (d), 
1 12.3 (d), 1 14.0 (d, 2 C), 1 17.5 (s), 1 19.4 (d), 120.2 (d), 124.3 (d), 125.2 
(s), 127.2 (d, 2 C), 127.9 (s), 128.5 (d), 129.0 (d), 130.0 (s), 135.9 (s), 
152.8 (s), 158.0 (s), 163.5 (s), 168.0 (s), 169.3 (s), 170.3 (s), 170.6 (s), 
171.3 (s),174.5 (s,2C);MS m/z= 978.4(M+);HRFABMS obsdm/z 
= 961.4256 (M + H - HzO)', C ~ ~ H ~ I N S O I ~  requires m/z = 961.4307. 
Dehydration of Microsclerodermin A (1). A solution of microscle- 
roderminA(1,ll mg) inDMSO (200pL) wasdilutedwith l.O%aqueous 
TFA (to 2 mL). The resulting solution was warmed to 35 OC for 5 min, 
diluted with water to 5 mL, and lyophilized immediately. The reaction 
mixture was purified by HPLC (YMC ODs-AM 45% CH3CN in 0.05% 
TFA at 3.4 mL/min; UV detection, 215 nm) to obtain starting material 
(1,l mg) and dehydromicrosclerodermin A (3,8 mg, 80% yield): white 
powder, NMR (DMSO-d6) see Table 2; 13C NMR (DMSO-da) see 
Table 2; HRFABMS obsd m/z = 977.4285 (M + H)+, C ~ $ - I ~ ~ N S O I ~  
requires m / z  = 977.4256. 
Acetylation of Microsclerodermin A (1). A solution of microsclero- 
dermin A (1,500 pg), acetic anhydride (95 pL), DMAP (100 pg), and 
pyridine (200 pL) was stirred at 4 OC overnight. The reagents were 
removed under high vacuum, and the residue was dissolved in aqueous 
CH3CN (lOOpL), filtered,and purified by reversed-phase HPLC eluting 
with a linear gradient from 30 to 70% CH3CN in 0.05% aqueous TFA 
over 40 min at a flow rate of 3.4 mL/min. The major product eluted at 
37.9 min and showed a mass of m/z = 1187, indicating the formation 
of a pentaacetate of dehydromicrosclerodermin A (3), which was not 
characterized further. 
Acetylation of Dehydromicrosclerodermin A (3). A solution of 
dehydromicrosclerodermin A (3, 500 pg), acetic anhydride (95 pL), 
DMAP (100 pg), and pyridine (200 pL) was stirred at 4 OC overnight. 
The experiment was worked up as shown above to obtain a pentaacetate 
that showed identical HPLC behavior to that obtained from 1. 
Methylation of Microsclerodermin A (1). A solution of microscle- 
rodermin A (1, 2 mg) in EtOH (1 mL) was placed in the collection 
chamber of an MNNG-diazomethane generator (Aldrich) and cooled to 
O OC before distilling CHzNz directly into the solution. The solution was 
warmed to room temperature and the reaction left overnight. The EtOH 
was removedunder highvacuum, and theresidue was dissolved in aqueous 
CH3CN (200 pL) and purified by reversed-phase HPLC eluting with a 
linear gradient from 30 to 70% CH3CN in 0.05% aqueous TFA over 40 
min at a flow rate of 3.4 mL/min. The major product eluted at 23.8 min 
and showed a mass of m/z = 1008, indicating the formation of a 
monomethyl ester. The IH NMR spectrum contained a new methyl 
signal at 8 3.67 (s, 3 H). 
Acetonide of Dehydromicrosclerodermin A (3). Under an atmosphere 
of dry ntirogen, 2,2-dimethoxypropane (400 pL) was added to a stirred 
solution of dehydromicrosclerodermin A (3,8 mg) andp-toluenesulfonic 
acid (2 mg) in dry DMF (2 mL). The reaction was stopped after 6 h, 
whennofurtherreactioncouldbeobservedby TLC (silicagel,21 EtOAc- 
MeOH), by addition of pyridine (20 pL) and removal of excess reagent 
in a stream of nitrogen. The solvent was removed under high vacuum. 
The residue was dissolved in 1:l CH~CN-HZO (1 mL) and purified by 
HPLC (YMC ODs-AM; six injections; linear gradient, 30-50% CH3- 
CN in 0.01 M NH4C1, pH 5.0 over 30 min at 3.4 mL/min; UV detection, 
220 nm), which gave the starting material 3 (10 min) and the acetonide 
4 (22 min): IR (KBr) 3340,2930,1735,1660,1540 cm-1; UV (MeOH) 
(nm) 205 (e 11 loo), 262 (a 7000), 268 (sh, a 6800), 285 (e 4900); IH 
NMR (5:l acetone-d6-DMSO-d6) 8 0.86 (d, 3 H, J = 6.5 Hz, H-19), 
1.10 (m, 1 H, H-7), 1.12 (m, 1 H, H-8), 1.34 (s, 3 H, H-50), 1.38 (m, 
2 H, H-9), 1.39 (m, 1 H, H-83,1.40 (s, 3 H, H-49), 1.42 (m, 1 H, H-7'), 
2.15 (m, 2 H, H-lo), 2.20 (m, 1 H, H-22), 2.30 (m, 2 H, H-22', -24), 
3.20 (s, 3 H, H-41), 3.26 (m, 1 H, H-24'), 3.30 (dd, 1 H, J = 17.5,5.5 
(14) Lawry, N. H.; Jani, V.; Jensen, T. E. Cum. Microbiol. 1981,6, 71. 
(15) (a) Braunschweiler, L.; Ernst, R. R. J. Chem. Phys. 1976,64,2229. 
(I 6) The 0.1 M N&NCO3 buffer is used to increase the solubility of the 
(b) Davis, D. G.; Bax, A. J.  Am. Chem. Soc. 1985,107,2820. 
peptide. 
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Hz, H-26), 3.44 (d, 1 H, J =  16 Hz, H-40), 3.48 (dd, 1 H, J = 13, 5.5 
Hz, H-29), 3.59 (dd, 1 H, J = 13,5.5 Hz, H-293, 3.74 (s, 3 H, H-20), 
3.82(dd, 1 H , J =  5.5,5.5H~,H-5),3.96 (dd, 1 H,J= 10,5.5Hz,H-4), 
1 H, J = 5.5, 5.5,5 Hz, H-28 ), 4.34 (d, 1 H, J = 16 Hz, H-40’), 4.44 
3.89 (dd, 1 H, J =  17.5,5.5 Hz, H-26’),4.02 (m, 1 H, H-23), 4.22 (ddd, 
(br s, 1 H, H-2), 4.45 (dd, 1 H, J = 10,8.5 Hz, H-3), 4.48 (d, 1 H, J 
=5.5Hz,H-46),4.92(brd,1H2J=5.5Hz,H-45),5.31 (s,lH,H-43), 
6.12 (ddd, 1 H , J =  15.5, 7, 7 Hz, H-l l ) ,  6.32 (d, 1 H, J =  15.5 Hz, 
H-12), 6.84 (d,’2 H, J = 8.5 Hz, H-15, -17), 7.05 (dd, 1 H, J = 8, 8 
= 5.5, 5.5 Hz, NH-24), 7.20 (dd, 1 H, J = 8, 8 Hz, H-36), 7.28 (d, 2 
H, J = 8.5 Hz, 8 1 4 ,  -18), 7.45 (d, 1 H, J = 8 Hz, H-37), 7.50 (d, 1 
H, J = 6 Hz, NH-3), 7.65 (d, 1 H, J = 8 Hz, H-34), 7.65 (d, 1 H, J = 
Hz, H-39, 7.08 (dd, 1 H, J = 5.5, 5.5 Hz, NH-26), 7.17 (br t, 1 H, J 
5 Hz,NH-28), 8.10 (br s, 1 H, NH-45), 10.45 (s, 1 H, NH-44); FABMS 
m/z = 1017 (M + H)+. 
Determination of Absolute Configuration. (A) Hydrolyses with 6 N 
HCI. A solution of the peptide or degradation products in degassed 6 N 
hydrochloric acid (500-800 pL) was heated in a sealed tube for 12-24 
hand then cooled. The solvent was removed in a stream of dry nitrogen, 
with heating, and under high vacuum. 
(b) Derivatization. A premixed solution of acetyl chloride (1 part) in 
isopropanol (4 parts) (0.5-0.8 mL) was added to each of the hydrolysates 
in a 1-mL thick-walled reaction vial, and the vial was securely capped. 
The solution was heated to 100 OC for 45 min and cooled, and the solvent 
was removed in a stream of dry nitrogen. Pentafluoropropionic anhydride 
(400 pL) in CH2CL2 (400 pL) was added to the residue, the vial was 
capped, the solution was heated at 100 OC for 15 min and cooled, and 
the solvent was removed in a stream of dry nitrogen followed by high 
vacuum. The residue was dissolved in CHzClz (100 pL) and immediately 
analyzed by GC-MS using a chiral column. The identity of each peak 
was confirmed by coinjection with a solution of a standard that had been 
derivatized in the same manner. Retention times (i minutes) for the 
standards, using theexperimental protocol above, are as follows: glycine, 
10.1; 3-hydroxy-4-aminobutyric acid, (3R) 29.15, (3s) 29.37; aspartic 
acid, (R) 26.63, (S) 26.83;3-hydroxyasparticacid, (2R,3R) 21.64, (2S,3S) 
22.02, (2R,3S) 24.04, (2S,3R) 24.31. 
(c) 3-Hydroxy-4-aminobutyric Acid. A degassed solution of micro- 
sclerodermin A (1,200 pg) in neat methanesulfonic acid (100 pL) was 
heatedat 110 OCinasealedtubefor24h. Becausethesolventisessentially 
nonvolatile, approximately half of the reaction product was derivatized 
as described in b above. A 191 mixture of (R)- and (S)-3-hydroxy-4- 
aminobutyric acids was obtained. 
(d) Ozonolysis of Mcrosclerodermh A (1). A stream of ozone in 
argon was bubbled into a cooled solution of microsclerodermin A (1,400 
fig) in dry MeOH (1.5 mL) at -70 OC for 20 min. The excess reagent 
was removed in a stream of dry nitrogen as the solution was warmed to 
Bewley et al. 
20 OC. Thesolvent was removed under reduced pressure, and theozonide 
was redissolved in a 2 1  mixture of formic acid and hydrogen peroxide. 
The solution was heated over a period of 30 min to 80 “C and coold, 
and excess reagents were removed under reduced pressure. The reaction 
product was hydrolyzed and derivatized as described in a and b above. 
A peak in the GC trace corresponding to (R)-aspartic acid was derived 
from (R)-tryptophan-2-carboxylic acid. 
(e) Ozonolysis of Dehydromicrosclerodermin A (3). Dehydromicro- 
sclerodermin A (3,400 pL) was ozonized using the procedure described 
above (d). The reaction product was hydrolyzed and derivatized as 
described in a and b above. A peak in the GC trace corresponding to 
(2S,3R)-j3-hydroxyaspartic acid was derived from carbons 44-47 in 3 
(and 1). I 
(f) Periodate Oxidation of Microsclerodermin A (1). A solution of 
microsclercdermin A (1,2 mg) and sodium periodate (200 pg) in water 
(0.5 mL), adjusted to pH 4.0 with acetic acid, was stirred ovemight at 
25 OC. The solvent was lyophilized, and thk residue was dissolved in 
hydrogen peroxide (2 mL) and formic acid (1 mL). The solution was 
heated at 70 OC for 20 min and cooled, and the solvent was evaporated 
under reduced pressure. The reaction product was hydrolyzed end 
derivatized as described in a and b above. A peak in the GC trace 
mrresponding to (2S,3s)-@-hydroxyasparticadid wasderived fromcarbons 
1-4 in 1. 
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